Search results
Applied Filters
- image-guided biopsy
Publication Date
Author
- Pinto, Peter A10
- Turkbey, Baris9
- Choyke, Peter L7
- Wood, Bradford J7
- Merino, Maria J6
- Bjurlin, Marc A4
- Marks, Leonard S4
- Bloom, Jonathan B3
- Czarniecki, Marcin3
- Gold, Samuel A3
- Hale, Graham R3
- Margolis, Daniel J3
- Mehralivand, Sherif3
- Rayn, Kareem N3
- Reiter, Robert E3
- Rosenkrantz, Andrew B3
- Sidana, Abhinav3
- Taneja, Samir S3
- Ahmed, Hashim U2
- Albers, Peter2
- Antoch, Gerald2
- Arsov, Christian2
- Beyersdorff, Dirk2
- Budäus, Lars2
- Carroll, Peter R2
Publication Title
1 - 20of36
Save this search
Please login to be able to save your searches and receive alerts for new content matching your search criteria.
| Search Name | Searched On |
|---|---|
| Keyword: image-guided biopsy (36) | 13 Aug 2022 |
You do not have any saved searches
- No AccessReview Article01 September 2014
- Marc A. BjurlinMarc A. Bjurlin,
Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York
- Xiaosong MengXiaosong Meng,
Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York
- Julien Le NobinJulien Le Nobin,
Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York
- James S. WysockJames S. Wysock,
Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York
- Herbert LeporHerbert Lepor,
Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York
- Andrew B. RosenkrantzAndrew B. Rosenkrantz, and
Department of Radiology, New York University Langone Medical Center, New York, New York
- Samir S. TanejaSamir S. Taneja
Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York
Department of Radiology, New York University Langone Medical Center, New York, New York
Preview AbstractPurpose: Optimization of prostate biopsy requires addressing the shortcomings of standard systematic transrectal ultrasound guided biopsy, including false-negative rates, incorrect risk stratification, detection of clinically insignificant disease and the ...
No Access01 July 2016
- Raju ChelluriRaju Chelluri,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Amichai KilchevskyAmichai Kilchevsky,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Arvin K. GeorgeArvin K. George,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Abhinav SidanaAbhinav Sidana,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Thomas P. FryeThomas P. Frye,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Daniel SuDaniel Su,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Michele FascelliMichele Fascelli,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Richard HoRichard Ho,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Steven F. AbboudSteven F. Abboud,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Baris TurkbeyBaris Turkbey,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Maria J. MerinoMaria J. Merino,
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter L. ChoykePeter L. Choyke,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Bradford J. WoodBradford J. Wood, and
Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter A. PintoPeter A. Pinto
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Preview AbstractPurpose: Urologists face a dilemma when a lesion identified on multiparametric magnetic resonance imaging is benign on image guided fusion biopsy. We investigated the detection rate of prostate cancer on repeat fusion biopsy in multiparametric magnetic ...
No Access01 August 2016
- Pedro RecabalPedro Recabal,
Urology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York
Urology Service, Fundacion Arturo Lopez Perez, Santiago, Chile
- Melissa AsselMelissa Assel,
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
- Daniel D. SjobergDaniel D. Sjoberg,
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
- Daniel LeeDaniel Lee,
Department of Urology, Weill-Cornell Medical College, New York Presbyterian Hospital, New York, New York
- Vincent P. LaudoneVincent P. Laudone,
Urology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York
- Karim TouijerKarim Touijer,
Urology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York
- James A. EasthamJames A. Eastham,
Urology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York
- Hebert A. VargasHebert A. Vargas,
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
- Jonathan ColemanJonathan Coleman, and
Urology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York
- Behfar EhdaieBehfar Ehdaie
Urology Service, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
Preview AbstractPurpose: We determined whether multiparametric magnetic resonance imaging targeted biopsies may replace systematic biopsies to detect higher grade prostate cancer (Gleason score 7 or greater) and whether biopsy may be avoided based on multiparametric ...
No Access01 August 2016
- Khanh N. Pham,
- Jennifer CullenJennifer Cullen,
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, Maryland
- Lauren M. HurwitzLauren M. Hurwitz,
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland
- Erika M. Wolff,
- Katherine E. LevieKatherine E. Levie,
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland
- Katherine Odem-DavisKatherine Odem-Davis,
Center for Biomedical Statistics, Seattle, Washington
Institute of Translational Health Sciences, Seattle, Washington
- John S. Banerji,
- Inger L. RosnerInger L. Rosner,
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Urology Service, Walter Reed National Military Medical Center, Bethesda, Maryland
- Timothy C. BrandTimothy C. Brand,
Madigan Army Medical Center, Tacoma, Washington
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
- James O. L’EsperanceJames O. L’Esperance,
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Naval Medical Center San Diego, San Diego, California
- Joseph R. SterbisJoseph R. Sterbis, and
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Tripler Army Medical Center, Honolulu, Hawaii
- Christopher R. PorterChristopher R. Porter
Virginia Mason, Seattle, Washington
Center for Prostate Disease Research, Department of Defense, Rockville, Maryland
Preview AbstractPurpose: Active surveillance is an important alternative to definitive therapy for men with low risk prostate cancer. However, the impact of active surveillance on health related quality of life compared to that in men without cancer remains unknown. In ...
No Access01 September 2016
- Daniel J. LeeDaniel J. Lee,
Department of Urology, Weill-Cornell Medical College, New York Presbyterian Hospital, New York, New York
- Pedro RecabalPedro Recabal,
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
Urology Service, Fundacion Arturo Lopez Perez, Santiago, Chile
- Daniel D. SjobergDaniel D. Sjoberg,
Health Outcomes Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
- Alan ThongAlan Thong,
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
- Justin K. LeeJustin K. Lee,
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
- James A. EasthamJames A. Eastham,
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
- Peter T. ScardinoPeter T. Scardino,
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
- Hebert Alberto VargasHebert Alberto Vargas,
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
- Jonathan ColemanJonathan Coleman, and
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
- Behfar EhdaieBehfar Ehdaie
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
Health Outcomes Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
Preview AbstractPurpose: We compared the diagnostic outcomes of magnetic resonance-ultrasound fusion and visually targeted biopsy for targeting regions of interest on prostate multiparametric magnetic resonance imaging.
Materials and Methods: Patients presenting for ...
No Access01 February 2017
- Akhil MuthigiAkhil Muthigi,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Arvin K. GeorgeArvin K. George,
Department of Urology, University of Michigan, Ann Arbor, Michigan
- Abhinav SidanaAbhinav Sidana,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Michael KongnyuyMichael Kongnyuy,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Richard SimonRichard Simon,
Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Vanessa MorenoVanessa Moreno,
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Maria J. MerinoMaria J. Merino,
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter L. ChoykePeter L. Choyke,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Baris TurkbeyBaris Turkbey,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Bradford J. WoodBradford J. Wood, and
Center for Interventional Oncology, National Cancer Institute and Clinical Center, National Institutes of Health, Bethesda, Maryland
- Peter A. PintoPeter A. Pinto
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Preview AbstractPurpose: Multiparametric magnetic resonance imaging and fusion biopsy detect more high risk prostate cancer and less low risk prostate cancer than systematic biopsy. However, there remains a small subset of patients in whom systematic biopsy captures ...
No Access01 March 2017
Preview AbstractPurpose: We sought to determine the rate of upgrading to Gleason score 4 + 3 or greater using targeted biopsy for diagnosis and monitoring in men undergoing active surveillance of prostate cancer.
Materials and Methods: Study subjects comprised all 259 men,...
No Access01 October 2017- Pat F. FulghamPat F. Fulgham,
Texas Health Presbyterian Hospital of Dallas, Dallas, Texas
- Daniel B. RukstalisDaniel B. Rukstalis,
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
- Ismail Baris TurkbeyIsmail Baris Turkbey,
National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Jonathan N. RubensteinJonathan N. Rubenstein,
Chesapeake Urology Associates, Baltimore, Maryland
- Samir Taneja,
- Peter R. CarrollPeter R. Carroll,
University of California San Francisco, San Francisco, Calfornia
- Peter A. PintoPeter A. Pinto,
National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Marc A. Bjurlin, and
- Scott EggenerScott Eggener
The University of Chicago Medical Center, Chicago, Illinois
Preview AbstractPurpose: We summarize the available data about the clinical and economic effectiveness of magnetic resonance imaging in the diagnosis and management of prostate cancer, and provide practical recommendations for its use in the screening, diagnosis, staging ...
No Access01 March 2018
Preview AbstractPurpose: We systematically analyzed the records of patients with PI-RADS™ (Prostate Imaging Reporting and Data System) 3 lesions, which are called equivocal according to PI-RADS version 2, using prostate multiparametric magnetic resonance imaging and ...
No Access01 April 2018
- Brian P. CalioBrian P. Calio,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Abhinav SidanaAbhinav Sidana,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Division of Urology, University of Cincinnati College of Medicine, Cincinnati, Ohio
- Dordaneh SuganoDordaneh Sugano,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Sonia GaurSonia Gaur,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Mahir MarufMahir Maruf,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Amit L. JainAmit L. Jain,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Maria J. MerinoMaria J. Merino,
Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter L. ChoykePeter L. Choyke,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Bradford J. WoodBradford J. Wood,
Center for Interventional Oncology, National Cancer Institute and Clinical Center, National Institutes of Health, Bethesda, Maryland
- Peter A. PintoPeter A. Pinto, and
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Baris TurkbeyBaris Turkbey
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Preview AbstractPurpose: We sought to determine whether saturation of the index lesion during magnetic resonance imaging-transrectal ultrasound fusion guided biopsy would decrease the rate of pathological upgrading from biopsy to radical prostatectomy.
Materials and ...:
No Access01 July 2018
- Susan PrendevilleSusan Prendeville,
Department of Pathology, University Health Network, Toronto, Ontario, Canada
- Mark GertnerMark Gertner,
Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada
- Manjula MagantiManjula Maganti,
Department of Biostatistics, University Health Network, Toronto, Ontario, Canada
- Melania PintilieMelania Pintilie,
Department of Biostatistics, University Health Network, Toronto, Ontario, Canada
- Nathan PerlisNathan Perlis,
Division of Urology, Department of Surgery, University Health Network, Toronto, Ontario, Canada
- Ants ToiAnts Toi,
Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada
- Andrew J. EvansAndrew J. Evans,
Department of Pathology, University Health Network, Toronto, Ontario, Canada
- Antonio FinelliAntonio Finelli,
Division of Urology, Department of Surgery, University Health Network, Toronto, Ontario, Canada
- Theodorus H. van der KwastTheodorus H. van der Kwast, and
Department of Pathology, University Health Network, Toronto, Ontario, Canada
- Sangeet GhaiSangeet Ghai
Department of Medical Imaging, University Health Network, Toronto, Ontario, Canada
Preview AbstractPurpose: The aim of this study was to compare biopsy detection of intraductal and cribriform pattern invasive prostate carcinoma in multiparametric magnetic resonance imaging positive and negative regions of the prostate.
Materials and Methods: We queried ...
No Access01 August 2018
- Ashkan MortezaviAshkan Mortezavi,
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Olivia MärzendorferOlivia Märzendorfer,
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Olivio F. DonatiOlivio F. Donati,
Institutes of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Gianluca RizziGianluca Rizzi,
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Niels J. RuppNiels J. Rupp,
Surgical Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Marian S. WettsteinMarian S. Wettstein,
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
- Oliver GrossOliver Gross,
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Tullio SulserTullio Sulser,
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Thomas HermannsThomas Hermanns, and
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- Daniel EberliDaniel Eberli
Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
Preview AbstractPurpose: We evaluated the diagnostic accuracy of multiparametric magnetic resonance imaging and multiparametric magnetic resonance imaging/transrectal ultrasound fusion guided targeted biopsy against that of transperineal template saturation prostate ...
No Access01 August 2018
Preview AbstractPurpose: In this study we evaluated the diagnostic performance of transrectal ultrasound guided biopsy and multiparametric magnetic resonance imaging to detect prostate cancer against transperineal prostate mapping biopsy as the reference test.
Materials ...:
No Access01 November 2018- Pantelis DimitroulisPantelis Dimitroulis,
Department of Urology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Robert RabenaltRobert Rabenalt,
Department of Urology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Alessandro NiniAlessandro Nini,
Department of Urology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
Unit of Urology, Division of Oncology, Department of Urology, Istituto di Ricerca Urologica, Istituto di Ricovero e Cura a Carattere Scientifico Ospedale San Raffaele, Milan, Italy
- Andreas HiesterAndreas Hiester,
Department of Urology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Irene EspositoIrene Esposito,
Department of Pathology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Lars SchimmöllerLars Schimmöller,
Department of Diagnostic and Interventional Radiology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Gerald AntochGerald Antoch,
Department of Diagnostic and Interventional Radiology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Peter AlbersPeter Albers, and
Department of Urology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
- Christian ArsovChristian Arsov
Department of Urology, University Hospital Düsseldorf, Heinrich-Heine University Medical Faculty, Düsseldorf, Germany
Preview AbstractPurpose: For multiparametric magnetic resonance imaging/ultrasound fusion prostate biopsy the number of biopsy cores obtained is arbitrarily established by urologists. Moreover, a general consensus is lacking on the number of biopsy cores to be obtained ...
No Access01 October 2018
- Sebastian L. HofbauerSebastian L. Hofbauer,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Andreas MaxeinerAndreas Maxeiner,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Beatrice KittnerBeatrice Kittner,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Robin HeckmannRobin Heckmann,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Maximillian ReimannMaximillian Reimann,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Laura WiemerLaura Wiemer,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Patrick AsbachPatrick Asbach,
Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Matthias HaasMatthias Haas,
Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Tobias PenzkoferTobias Penzkofer,
Department of Radiology, Charité-Universitätsmedizin Berlin, Berlin, Germany
Berlin Institute of Health, Berlin, Germany
- Carsten StephanCarsten Stephan,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Frank FriedersdorffFrank Friedersdorff,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Florian FullerFlorian Fuller,
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Kurt MillerKurt Miller, and
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
- Hannes CashHannes Cash
Department of Urology, Charité-Universitätsmedizin Berlin, Berlin, Germany
Preview AbstractPurpose: The second version of the PI-RADS™ (Prostate Imaging Reporting and Data System) was introduced in 2015 to standardize the interpretation and reporting of prostate multiparametric magnetic resonance imaging. Recently low cancer detection rates ...
No Access01 November 2018
- Kareem N. RaynKareem N. Rayn,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Jonathan B. BloomJonathan B. Bloom,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Samuel A. GoldSamuel A. Gold,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Graham R. HaleGraham R. Hale,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Joseph A. BaioccoJoseph A. Baiocco,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Sherif MehralivandSherif Mehralivand,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Department of Urology and Pediatric Urology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Mainz, Germany
- Marcin CzarnieckiMarcin Czarniecki,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Vikram K. SabarwalVikram K. Sabarwal,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Vladimir ValeraVladimir Valera,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Bradford J. WoodBradford J. Wood,
Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Maria J. MerinoMaria J. Merino,
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter ChoykePeter Choyke,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Baris TurkbeyBaris Turkbey, and
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter A. PintoPeter A. Pinto
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Preview AbstractPurpose: We examined the additional value of preoperative prostate multiparametric magnetic resonance imaging and transrectal ultrasound/multiparametric magnetic resonance imaging fusion guided targeted biopsy when performed in combination with clinical ...
No Access01 November 2018
- Xiaosong MengXiaosong Meng,
Department of Urology, New York University Langone Health, New York, New York
- Andrew B. RosenkrantzAndrew B. Rosenkrantz,
Department of Radiology, New York University Langone Health, New York, New York
- Richard HuangRichard Huang,
Department of Urology, New York University Langone Health, New York, New York
- Fang-Ming DengFang-Ming Deng,
Department of Pathology, New York University Langone Health, New York, New York
- James S. WysockJames S. Wysock,
Department of Urology, New York University Langone Health, New York, New York
- Marc A. BjurlinMarc A. Bjurlin,
Department of Urology, New York University Langone Hospital-Brooklyn, Brooklyn, New York
- William C. HuangWilliam C. Huang,
Department of Urology, New York University Langone Health, New York, New York
- Herbert LeporHerbert Lepor, and
Department of Urology, New York University Langone Health, New York, New York
- Samir S. TanejaSamir S. Taneja
Department of Urology, New York University Langone Health, New York, New York
Department of Radiology, New York University Langone Health, New York, New York
Preview AbstractPurpose: While magnetic resonance imaging-ultrasound fusion targeted biopsy allows for improved detection of clinically significant prostate cancer, a concerning amount of clinically significant disease is still missed. We hypothesized that a number of ...
No Access01 November 2018- Sami-Ramzi Leyh-BannurahSami-Ramzi Leyh-Bannurah,
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
- Mykyta KachanovMykyta Kachanov,
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
- Dirk BeyersdorffDirk Beyersdorff,
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
- Felix PreisserFelix Preisser,
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada
- Derya TilkiDerya Tilki,
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
- Margit FischMargit Fisch,
Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany
- Markus GraefenMarkus Graefen, and
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
- Lars BudäusLars Budäus
Martini-Klinik, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany
Preview AbstractPurpose: Based on findings in transrectal ultrasound guided biopsy series standard sampling of the prostate targets the posterior/peripheral zone. However, a substantial proportion of lesions that are prostate cancer suspicious and PI-RADS™ (Prostate ...
No AccessNew Technology and Techniques01 November 2018
- Graham R. HaleGraham R. Hale,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Marcin CzarnieckiMarcin Czarniecki,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Alexis ChengAlexis Cheng,
Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Jonathan B. BloomJonathan B. Bloom,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Reza SeifabadiReza Seifabadi,
Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Samuel A. GoldSamuel A. Gold,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Kareem N. RaynKareem N. Rayn,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Vikram K. SabarwalVikram K. Sabarwal,
Department of Urology, George Washington University, Washington, D. C.
- Sherif MehralivandSherif Mehralivand,
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Department of Urology and Pediatric Urology, University Medical Center Mainz, Johannes Gutenberg University Mainz, Germany
- Peter L. ChoykePeter L. Choyke,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Baris TurkbeyBaris Turkbey,
Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Brad WoodBrad Wood, and
Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
- Peter A. PintoPeter A. Pinto
Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland
Preview AbstractPurpose: The relative value of rigid or elastic registration during magnetic resonance imaging/ultrasound fusion guided prostate biopsy has been poorly studied. We compared registration errors (the distance between a region of interest and fiducial ...
No Access01 December 2018- Saiful MiahSaiful Miah,
Division of Surgery and Interventional Science, University College London, London, United Kingdom
Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom
- David Eldred-EvansDavid Eldred-Evans,
Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom
- Lucy A.M. SimmonsLucy A.M. Simmons,
Division of Surgery and Interventional Science, University College London, London, United Kingdom
- Taimur T. ShahTaimur T. Shah,
Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom
- Abi KanthabalanAbi Kanthabalan,
Division of Surgery and Interventional Science, University College London, London, United Kingdom
- Manit AryaManit Arya,
Department of Urology, University College London Hospital, London, United Kingdom
- Mathias WinklerMathias Winkler,
Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom
- Neil McCartanNeil McCartan,
Division of Surgery and Interventional Science, University College London, London, United Kingdom
- Alex FreemanAlex Freeman,
Department of Pathology, University College London Hospital, London, United Kingdom
- Shonit PunwaniShonit Punwani,
Department of Radiology, University College London Hospital, London, United Kingdom
- Caroline M. MooreCaroline M. Moore,
Division of Surgery and Interventional Science, University College London, London, United Kingdom
- Mark EmbertonMark Emberton, and
Division of Surgery and Interventional Science, University College London, London, United Kingdom
- Hashim U. AhmedHashim U. Ahmed
Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom
Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom
Preview AbstractPurpose: Transperineal template prostate mapping biopsy is an increasingly used method of procuring tissue from men with suspected prostate cancer. We report patient related outcome measures and adverse events in men in the PICTURE trial (...
- Marc A. Bjurlin